What is the global market size of Embolic Protection Devices Market?

Embolic Protection Devices Market size was valued at USD 0.51 Billion in 2021 and is poised to grow from USD 0.60 Billion in 2022 to USD 1.13 Billion by 2030, at a CAGR of 8.2% during the forecast period (2023-2030).

Who are the key vendors in the Global Embolic Protection Devices Market?

The competitive landscape of the Global Embolic Protection Devices Market is characterized by intense competition and the presence of several key players. These players are actively engaged in research and development activities to introduce technologically advanced and innovative embolic protection devices. They focus on strategic collaborations, partnerships, and acquisitions to expand their product portfolios and strengthen their market position. Additionally, companies in the market strive to obtain regulatory approvals and certifications to ensure compliance with safety and quality standards. The market is witnessing a continuous influx of new entrants, which further intensifies the competition. Overall, the competitive landscape of the embolic protection devices market is dynamic and driven by innovation, product differentiation, and the ability to meet the evolving needs of healthcare professionals and patients. 'Boston Scientific Corp. (US)', 'Edwards Lifesciences (US)', 'Abbott Laboratories (US)', 'Medtronic Plc (Ireland)', 'Cardinal Health (US)', 'Claret Medical, Inc. (US)', 'Innovative Cardiovascular Solutions, LLC (US)', 'Transverse Medical, Inc. (US)', 'Gore Medical (US)', 'Allium Medical (Israel)', 'Contego Medical, LLC (US)', 'Keystone Heart Ltd. (US)', 'InspireMD, Inc. (Israel)', 'Cardiovascular Systems, Inc. (US)', 'Silk Road Medical, Inc. (US)', 'AngioDynamics, Inc. (US)', 'Emboline, Inc. (US)', 'Contego Medical, LLC (US)', 'Acandis GmbH & Co. KG (Germany)', 'Veryan Medical Ltd. (UK)'

What is the key driver of Global Embolic Protection Devices Market?

One key driver of the Global Embolic Protection Devices Market is the increasing prevalence of cardiovascular diseases. The rising incidence of cardiovascular diseases, such as coronary artery disease, peripheral artery disease, and valvular heart disease, is driving the demand for embolic protection devices. These devices play a crucial role in preventing complications during invasive cardiovascular procedures, thereby improving patient outcomes.

What is the key market trend for Global Embolic Protection Devices Market?

Increasing adoption of minimally invasive procedures: One key market trend in the Global Embolic Protection Devices Market is the increasing adoption of minimally invasive procedures. Minimally invasive techniques, such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and percutaneous coronary intervention (PCI), are gaining popularity due to their advantages of reduced hospital stay, faster recovery, and lower risk of complications compared to traditional open surgeries. As a result, there is a growing demand for embolic protection devices that can effectively mitigate the risk of emboli during these minimally invasive procedures. This trend is driving the development and innovation of embolic protection devices that are specifically designed for use in minimally invasive interventions, catering to the evolving needs of healthcare professionals and patients alike.

Which region accounted for the largest share in Global Embolic Protection Devices Market?

The dominant segment in the Global Embolic Protection Devices Market based on region is North America. North America holds a significant share in the market due to factors such as well-established healthcare infrastructure, high healthcare expenditure, and a large patient population with cardiovascular diseases. The presence of key market players, technological advancements, and early adoption of innovative medical devices contribute to the dominance of North America in the market. Additionally, favorable reimbursement policies and a robust regulatory framework further support the growth of the embolic protection devices market in this region.

Embolic Protection Devices Market Size, Share, Growth Analysis, By Type(Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices), By Material(Nitinol, Polyurethane), By Indication(Percutaneous Coronary Intervention, Carotid Artery Diseases, Saphenous Vein Graft Disease, Transcatheter Aortic Valve Replacement), By Application(Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases), By End User(Hospitals, Ambulatory Surgical Centers), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2683 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 62 | Figures: 75

Embolic Protection Devices Market News

In April 2024, Embolin, Inc. announced the acquisition of SWAT Medical’s embolic protection intellectual property portfolio. The acquisition is expected to expand Emboline's existing platform technology and reduce the risk of infection caused by embolic debris thrown into the bloodstream.
In September 2022, the Boston Science Foundation revealed the results of a clinical trial of PROTECTED TAVR evaluating the SENTINEL brain protection system designed to capture and eliminate embolic debris from the replacement of the transcatheter aortic valve before it can reach the brain and potentially cause a stroke. Such advancements helped to retain the company's brand image while also extending the company's customer portfolio.
In February 2022, Cardiovascular Systems, Inc. initiated a recall of its WIRION Embolic Protection Device due to issues with filter breakage during recovery.

Embolic Protection Devices Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

US Embolic Protection Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

The embolic protection devices industry is highly competitive, driven by innovations and technological advancements of established players and emerging companies. Key players like Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Medtronic expand their R&D capabilities in a complex, large distribution network. These companies manage the market with their ideas and have focused on the development of next-generation EPDs that provide improved safety, accuracy, and ease of use. Strategic partnerships and acquisitions play an important role in shaping market dynamics. 'Medtronic ', 'Abbott Laboratories ', 'Boston Scientific ', 'Contego Medical ', 'Silk Road Medical ', 'Claret Medical ', 'Allium Medical Solutions ', 'Edwards Lifesciences ', 'Healthcare Solutions Holding, LLC ', 'Innovative Cardiovascular Solutions, LLC ', 'Transverse Medical, Inc. ', 'Keystone Heart Ltd. ', 'InspireMD, Inc. ', 'AngioDynamics, Inc. ', 'Emboline, Inc. ', 'Acandis GmbH & Co. KG ', 'Veryan Medical Ltd. ', 'Shanghai MicroPort Medical Co., Ltd. ', 'MedNova, Inc.'

Rising Adoption of Transcatheter Aortic Valve Replacement (TAVR) Techniques: The increasing availability of transcatheter aortic valve replacement (TAVR) techniques has led to a demand for embolic protection devices. TAVR is a relatively safe option for the treatment of aortic valve stenosis, a condition that frequently produces embolic debris during intervention. The use of EPDs in TAVR procedures reduces the risk of stroke and other complications.

As per embolic protection devices market outlook, North America is the dominant region in embolic protective devices market, mainly due to advanced healthcare, high prevalence of cardiovascular diseases and high adoption of minimally invasive procedures. The US especially leads the market with the presence of key players such as Boston Scientific and Abbott Laboratories, who constantly introduce new EPDs. Furthermore, they focused on reducing the burden of cardiovascular diseases driving high demand for EPDs of transcatheter aortic valve replacement (TAVR) procedures and other interventional surgeries. Government policies also contribute to the dominance of the market in the United States.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Embolic Protection Devices Market News

Embolic Protection Devices Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Embolic Protection Devices Market?

Who are the key vendors in the Embolic Protection Devices Market?

What is the key driver of Embolic Protection Devices Market?

What is the key market trend for Embolic Protection Devices Market?

Which region accounted for the largest share in Embolic Protection Devices Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300